Sep.23(Fri.)-25(Sun.), Grand Ballroom
[Speaker]
강동선
Dong-Seon Kang, MD*1; Daehoon Kim, MD*1; Eunsun Jang, MS1; Hee Tae Yu, MD1; Tae-Hoon Kim, MD1; Hui-Nam Pak, MD1; Jung-Hoon Sung, MD2; Moon-Hyoung Lee, MD1; Pil-Sung Yang, MD†2; Boyoung Joung, MD†1
1Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea
2Department of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Korea
*The first two authors contributed equally to this work.
†Joint senior authors
[Speaker]
강동선
Dong-Seon Kang, MD; Daehoon Kim, MD; Je-Wook Park, MD; Hee Tae Yu, MD, PhD; Tae-Hoon Kim, MD; Boyoung Joung, MD, PhD; Moon-Hyoung Lee, MD, PhD; Hui-Nam Pak, MD, PhD.
Yonsei University College of Medicine, Yonsei University Health System, Seoul, Republic of Korea
[Speaker]
최선영
Sun Young Choi1,2, Moo Hyun Kim1, Kwan-Min Lee1, Young-Shin Cha1, Da-Eun Koh1
1Department of Cardiology, Dong-A University Medical Center, Busan, Korea. 2Department of Biomedical Laboratory Science, Daegu Health College, Daegu, Korea
ABO Blood Type is Associated with Thrombotic Risk in Patients with Nonvalvular Atrial Fibrillation
[Speaker]
서정덕
Jeongduk Seo, MD1†; Albert Youngwoo Jang, MD1†; Yae Min Park, MD, PhD1; Yong Hoon Shin, MD1; Joonpyo Lee, MD1; Pyung Chun Oh, MD1; Woong Chol Kang, MD, PhD1; Wook-Jin Chung, MD, PhD1,*, Jeonggeun Moon, MD, PhD1,*
1Division of Cardiology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea
[Speaker]
임우현
Woo-Hyun Lim,1 So-Ryoung Lee,2 Eue-Keun Choi,2,3 Seung-Woo Lee,4 Kyung-Do Han,5 Seil Oh,2,3 Gregory Y. H. Lip3,6,7
1Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea
2Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea
3Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
4Department of Medical Statistics, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea
5Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea
6Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Chest and Heart Hospital, Liverpool, United Kingdom
7Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
[Speaker]
박한진
Hanjin Park, MD*;1 Daehoon Kim, MD*;1 Eunsun Jang, MS;1 Hee Tae Yu, MD;1 Tae-Hoon Kim, MD;1 Dong-min Kim, MD;2 Jung-Hoon Sung, MD;3 Hui-Nam Pak, MD;1 Moon-Hyoung Lee, MD;1 Pil-Sung Yang, MD;3† Boyoung Joung, MD, PhD1†
1Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
2Division of Cardiology, Department of Internal Medicine, Dankook University College of Medicine, Chungnam, Republic of Korea;
3Division of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea;
*These two authors contributed equally to this work.
The Impact of Metabolic Disorder on Incident End-Stage Renal Disease in Atrial Fibrillation
[Speaker]
권순일
Soonil Kwon1, So-Ryoung Lee1, Eue-Keun Choi1,2, Hyo-Jeong Ahn1, Seung-Woo Lee3, Kyung-Do Han4, Seil Oh1,2, Gregory Y. H. Lip5,6
1Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea
2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
3Department of Medical Statistics, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea
4Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea
5Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Chest & Heart Hospital, Liverpool, United Kingdom
6Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
[Speaker]
최성화
Sung Hwa Choi1, MD; Daehoon Kim1, MD; Je-Wook Park1, MD; Hee-Tae Yu1, MD, PhD; Tae-Hoon Kim1, MD; Jae-Sun Uhm1, MD, PhD; Boyoung Joung1, MD, PhD; Moon-Hyoung Lee1, MD, PhD; Hui-Nam Pak1, MD, PhD.
1Yonsei University Health System, Seoul, Republic of Korea
[Speaker]
박찬순
Chan Soon Park,1 Eue-Keun Choi,1,2* So-Ryoung Lee,1 Hyo-Jeong Ahn,1 Soonil Kwon,1 Sunhwa Kim,1 Suk Ho Sohn,3 Jae Woong Choi,3,4 Ho Young Hwang,3,4 Seil Oh1,2
1 Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea
2 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
3 Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Republic of Korea
4 Department of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea
[Speaker]
안현진
Hyun Jin Ahn, MD1, So-Ryoung Lee, MD, PhD1, Eue-Keun Choi, MD, PhD 1,2, Nan Young Bae, MD1, Hyo-Jeong Ahn, MD1, Soonil Kwon, MD1, Seung-Woo Lee, BSc3, Kyung-Do Han, PhD4, Seil Oh, MD, PhD1,2, Gregory Y. H. Lip, MD2,5,6
1Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea
2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
3Department of Medical Statistics, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea
4Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea
5Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Chest and Heart Hospital, Liverpool, United Kingdom
6Department of Clinical Medicine, Aalborg University, Aalborg, Denmark